AstraZeneca PLC Company Profile

Description: AstraZeneca PLC

AstraZeneca PLC, a biopharmaceutical company, discovers, develops, manufactures, and markets prescription pharmaceuticals in the areas of cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation illnesses worldwide. Its product line primarily comprises Crestor for managing cholesterol levels; Nexium for acid reflux; Synagis for RSV, a form of respiratory infection in infants; Seroquel for schizophrenia, bipolar disorder, and major depressive disorders; Arimidex for breast cancer; and Symbicort for asthma and chronic obstructive pulmonary disease. The company also engages in the research, development, manufacture, and marketing of medical devices and implants for use in urology, surgery, and odontology. In addition, it develops and manages hospital-based outpatient cancer centers in the United States. Further, the company focuses on the discovery and development of anti-viral therapies; and designs and manufactures bespoke dental implant abutments using a patented CAD/CAM method. The company markets its products primarily to care and specialist physicians, as well as to other healthcare professionals through distributors or local representative offices. AstraZeneca PLC has strategic alliances with Alcon Research, Ltd. to identify eye care products using AstraZeneca compounds; and Quintiles Limited to provide integrated services for various clinical pharmacology studies. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in London, the United Kingdom.

Company Profile

$24.95

 

 AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company. AstraZeneca discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Re...

Close Viewer

$125.00

 

 AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company that carries out designing, developing, production and marketing of various range of biologics, prescription pharmaceuticals and vaccines for the treatment of diseases such as cancer, ca...

Close Viewer

Prospectus IPO Registration and Annual Reports

 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer

Company Agreements and Contracts

 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer
 

 

Close Viewer

Cart Summary

Cart items will instantly download upon purchase.

There are no items in your cart
Your Savings: $0.00
Your Total: $0.00

Contact Info

Address:
15 Stanhope Gate, London,W1K 1LN, United Kingdom
Phone:
44 20 7304 5000
Revenue:
33.9B
Employees:
62700
Website:
http://www.astrazeneca.com

Executive Team

Mr. David R. Brennan
56, Chief Exec. Officer and Exec. Director
Mr. Simon Lowth
48, Chief Financial Officer, Exec. Director and Member of Disclosure Committee
Mr. David Smith
Exec. VP of Operations
Mr. Tony Zook
Exec. VP of Global Marketing and Exec. Vice-Pres of Commercial Operations, Chief Exec. Officer of AstraZeneca North America and Pres of MedImmune
Ms. Michele Volpe
Chief Exec. Officer and Exec. Director of Penn Presbyterian Medical Center

Competitors

GSK
GlaxoSmithKline plc
MRK
Merck & Co. Inc.
NVS
Novartis AG